Management will update stockholders on the Company’s recent COVID-19 related filings for Conditional EUA with the FDA in U.S., Interim Order in Canada, and accelerated rolling review in U.K., as well as potential similar filings in Brazil and the Philippines.

This statement seems quite clear, we filed for EUA in US, IO in Canada and the rolling review in UK, we will potentially make similar filings in Brazil and Philippines. Very clear, don't get the fuss.